Mounjaro is making headlines. We break down what this dual-action drug means for India’s diabetic population, comparing its efficacy against existing treatments and its long-term viability.
https://www.linkedin.com/pulse/can-indias-diabetic-population-truly-benefit-from-new-arya-jain-4ebpc
#Mounjaro #DiabetesResearch #AffordableHealthcare #IndianHealthcare #DiabetesMedication

